What Does the Sale of Progyny Shares by the CFO Mean for Investors?
Progyny delivers fertility benefits to employers nationwide; a key insider recently trimmed their stake, according to SEC filings.
Overview
Mark S. Livingston, Chief Financial Officer of Progyny (NASDAQ:PGNY), reported the sale of 8,275 shares of common stock in an open-market transaction on May 20, 2026, as disclosed in an SEC Form 4 filing.
Transaction value based on SEC Form 4 reported price ($25.50); post-transaction value based on May 20, 2026 trade-date close price.
Details
* 1-year performance metrics are calculated using May 20th, 2026 as the reference date.
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.